Pursuit Vascular

Maple Grove, United States Founded: 2009 • Age: 17 yrs Acquired By ICU Medical
Innovative single-use end caps for hemodialysis catheters are developed.

About Pursuit Vascular

Pursuit Vascular is a Healthcare company based in Maple Grove (United States) founded in 2009, and was acquired by ICU Medical in November 2019. Innovative single-use end caps for hemodialysis catheters are developed. Pursuit Vascular has raised $10.69 million across 6 funding rounds from investors including ICU Medical. The company has 7 employees. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Cardival Medical, Saranas and Aziyo Biologics; 3 of its 3 listed competitors have raised funding.

Company details

Pursuit Vascular was founded in 2009 and is located in Maple Grove, United States. The company operates in the medical device sector, where a family of single-use products is developed to prevent catheter-related infections and hospital-acquired diseases. ClearGuard HD end caps for hemodialysis catheters are among the offerings, and the device has been cleared by the FDA. Operations focus on infection prevention for vascular access.

Key Metrics
  • Total Equity Funding
    $10.69M (USD)

    in 6 rounds

  • Latest Funding Round
    $2.09M (USD), Series A

    Aug 2016

  • Investors
  • Employee Count
    7
  • Acquired by
    ICU Medical

    (Nov 2019)

Funding Insights of Pursuit Vascular

Pursuit Vascular has successfully raised a total of $10.69M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $2.09 million completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10.69M
  • Total Rounds 6
  • Last Round Series A — $2.09M
  • First Round $581,000

    (Mar 2012)

All 6 funding rounds of Pursuit Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2016$2.09MSeries A––
–
Apr 2015$5.11MSeries A––
–
Feb 2015$1.61MDebt – Conventional––
–
Feb 2014$1.57MSeries A––
–
Aug 2012$1.35MSeries A––
–
Mar 2012$581,000Seed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Pursuit Vascular

Pursuit Vascular has secured backing from 1 investor. Prominent investors backing the company include ICU Medical.

All
InvestorDescriptionFounded YearDomainLocation
Drug and Infusion delivery devices
1984icumed.comSan Clemente, United States
Premium access

Investor details for Pursuit Vascular

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Pursuit Vascular

4 dated milestones of Pursuit Vascular across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pursuit Vascular is founded.
  2. Funding First funding round of $581K.
  3. Funding Latest funding round, Series A, of $2.1M.
  4. Exit Acquired by ICU Medical.

Competitors of Pursuit Vascular

Pursuit Vascular has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Saranas and Aziyo Biologics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cardivamedical.com2002Santa Clara, United States$169.45M158
A device for vascular access management is developed.
saranas.com2011Houston, United States$29.46M
A device is developed for detecting internal bleeding during catheterization.
aziyo.com2015Silver Spring, United States$49.59M162
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
Premium access

Detailed competitors of Pursuit Vascular

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Pursuit Vascular (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pursuit Vascular

Premium access

Complete news archive for Pursuit Vascular

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pursuit Vascular

Pursuit Vascular was founded in 2009 and raised its 1st funding round 3 years after it was founded.

Pursuit Vascular is headquartered in Maple Grove, United States. It is registered at Maple Grove, Minnesota, United States.

Pursuit Vascular is a funded company, having raised a total of $10.69M across 6 funding rounds to date. The company's 1st funding round was a Seed of $581K, raised on Mar 2012.

Pursuit Vascular has 7 employees.

Pursuit Vascular was founded in 2009 and is located in Maple Grove, United States. The company operates in the medical device sector, where a family of single-use products is developed to prevent catheter-related infections and hospital-acquired diseases. ClearGuard HD end caps for hemodialysis catheters are among the offerings, and the device has been cleared by the FDA. Operations focus on infection prevention for vascular access.

Pursuit Vascular's top competitors include Cardival Medical, Aziyo Biologics and Saranas.

Pursuit Vascular has 1 investor. Key investors include ICU Medical.

Yes. Pursuit Vascular was acquired by ICU Medical in November 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available